Abstract:Debate is ongoing on the relationship between HIV infection and type 2 diabetes mellitus with increased risk and no difference described in European populations. A systematic review and meta-analysis were conducted to 1) determine the pooled prevalence of diabetes and prediabetes among people living with HIV (PLWH) in Africa, and 2) examine the magnitude of diabetes and prediabetes by sociodemographic characteristics, body mass index, definitions used for diabetes and prediabetes diagnoses, and HIV-related characteristics. A comprehensive search of major databases was conducted for original research articles published between 2000 and 2021. Relevant studies in English and French were included, irrespective of study design, data collection techniques and diagnostic definitions used. Study-specific estimates were pooled using random effects models to generate the overall prevalence of diabetes and prediabetes for each diagnostic definition and relevant sub-groups. Data analyses were conducted using the R statistical software and the “meta’’ package. Of the 2211 records initially screened, 54 were selected from 346 full-text articles assessed for eligibility. Most included studies were from South Africa (n = 15), Tanzania (n = 7), Ethiopia (n = 6), with four each from Cameroon, Malawi and Uganda. All studies were cross-sectional by design and clinic-based, except for four population-based studies. The proportion of men ranged from 16–52%. Mean/median age ranged from 29–62 years. Diabetes prevalence was 4.8% (95%CI: 4.02–5.59) among 101,704 participants; biochemical testing combined with self-reported diabetes yielded a higher prevalence (oral glucose tolerance test: 6.2%, 95%CI: 2.5–11.3; fasting blood glucose: 6.4%, 95%CI: 4.9–8.1) than self-reported diabetes prevalence alone (3.7%, 95%CI: 2.5–5.2). Prediabetes prevalence was 13.7% (95%CI: 10.21–17.59) among 13,502 participants. There were no statistically significant differences in diabetes or prediabetes prevalence by sub-groups examined, including CD4 count, and antiretroviral treatment status and duration. Diabetes prevalence in PLWH in Africa probably reflects that of general populations with similar influences. The lower prevalence of self-reported diabetes vs. biochemical testing with self-report possibly demonstrates suboptimal diabetes detection in this vulnerable group who are in regular contact with healthcare services. The high prevalence of prediabetes likely foreshadows a substantial increase in future diabetes in African PLWH.

Risk factors for progression from prediabetes to diabetes among older people with HIV

Incidence of diabetes mellitus and factors associated with its development in HIV-positive patients over the age of 50

Severe Dyslipidemia and Immune Activation in HIV Patients with Dysglycemia

Diagnosis and Risk Factors of Prediabetes and Diabetes in People Living with HIV- Evaluation of Clinical and Microbiome Parameters

Examining Incidence of Diabetes in People with HIV: Tracking the Shift in Traditional and HIV-related Risk Factors

Examining Incidence of Diabetes in People Living with HIV: Tracking the Shift in Traditional and HIV-related Risk Factors

[Prevalence and Related Factors on Diabetes among HIV/AIDS Receiving Antiretroviral Therapy in Dehong Dai and Jingpo Autonomous Prefecture].

[Incidence of diabetes and influencing factors in HIV-infected individuals after antiretroviral therapy in Dehong Dai and Jingpo Autonomous Prefecture]

Prevalence of hypertension and diabetes and associated risk factors among people living with human immunodeficiency virus in Southern Ethiopia

PREVALENCE OF DIABETES AND PREDIABETES AMONG ADULTS WITH HIV IN AFRICA: A SYSTEMATIC REVIEW AND META-ANALYSIS

Mechanisms underlying the development of type 1 diabetes in ART-treated people living with HIV: an enigmatic puzzle

Incident Proteinuria differs by HIV Serostatus among Men with Pre-diabetes: The Multicenter AIDS Cohort Study

Diabetes mellitus and associated risk factors among HIV infected patients on HAART

Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention : A Randomized Trial

Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile

Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus

Analysis of drug-drug interactions in patients with HIV and metabolic syndrome

Short Communication: Predictive Value of HIV-Related Versus Traditional Risk Factors for Coronary Atherosclerosis in People Aging with HIV

The Primacy of Adipose Tissue Gene Expression and Plasma Lipidome in Cardiometabolic Disease in Persons With HIV

Prevention and treatment of cardiovascular disease in HIV: practical insights in an evolving field